Role of the innate immune system in the pathogenesis of multiple sclerosis.
about
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneSignal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40LImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyIs Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative DiseasesInnate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune DiseasesComputational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic AnalysisThe Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple SclerosisPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesAssociation of Mycobacterium avium subsp. paratuberculosis with multiple sclerosis in Sardinian patientsIn vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.White matter damage and systemic inflammation in Parkinson's disease.Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.ProNGF mediates death of Natural Killer cells through activation of the p75NTR-sortilin complex.Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.Gut microbiome and the risk factors in central nervous system autoimmunity.Inflammasomes and autoimmunityMycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosisIncreased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.Multiple sclerosis: pathogenesis and treatment.Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cordSerum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases SusceptibilityBrain perfusion imaging with voxel-based analysis in secondary progressive multiple sclerosis patients with a moderate to severe stage of disease: a boon for the workforce.Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated processRapid Exercise-Induced Mobilization of Dendritic Cells Is Potentially Mediated by a Flt3L- and MMP-9-Dependent Process in Multiple Sclerosis.H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitisUpregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple SclerosisInfiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple SclerosisAutophagy and autoimmunity crosstalksImpaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationMicroglia play a major role in direct viral-induced demyelination11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan-treated rats.Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsNatural killer cells in human autoimmune disordersMicroRNAs and Multiple Sclerosis.Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.Toll-like receptors are key players in neurodegeneration.
P2860
Q21558407-4EF1E090-B37F-4B6A-9509-2AED39C83127Q24297472-53D09E37-30A5-41E8-9596-E22E88C85A32Q26745562-93CF7909-0C8A-4384-9B26-9C7CEE6B4F35Q26765787-DAE115A6-EF8E-4815-A849-CF4DE392751EQ26765847-AD34D3D5-6357-4171-B371-7770C090AC0AQ26774368-AD0C88F1-C1CD-46F3-B03B-007641980F76Q28076400-5BB03731-862D-4801-8074-923E1D9795B5Q28078621-35D7330E-89A4-4BAB-B791-F3FFBAB86E8DQ28741088-DD19024D-64CE-4B6E-A61A-B6DA72ABCA9FQ33558399-5F088843-534A-46F2-9E2E-26D7F8D84E70Q33781574-B176393E-D963-4D9C-A11F-C8FA76822316Q33851359-11E22ABB-6C81-4234-B9C7-AAF81E576759Q34117630-0CD98FDF-2100-4B2F-A2C5-4510D2EF0639Q34296297-F3114DDA-C40C-432B-BA87-EF9ADFD4A8D0Q34624054-42761EAC-BEE4-4DC8-AEB4-C34F8FD30DEFQ34670542-6CA263AD-6B07-4283-9413-78C72F79D515Q34713974-DDAE6303-19C3-4A29-9393-D79A8C8CCFE9Q35016997-A48D92F4-BE6D-4843-96A4-A24DB384C856Q35061290-F230F18D-88BC-4594-BCA1-215D9967B185Q35151851-DA54F8CE-63F6-4CC5-987F-9001282B5F48Q35156771-6EEC47E6-24C2-42D4-9754-20F56C5336B6Q35922211-0EE6E15F-0D80-41B7-BE40-390D32B51D83Q36031145-6DD54FF0-6DAF-4775-98B0-4583A4A61955Q36062897-984A60E2-D7A0-4016-A9E8-B054C5647157Q36271903-B133977D-C0F4-451C-BDA7-19FD999AE832Q36374681-BD546255-3C58-4187-9079-4EBC8E1C0A0BQ36500155-10387CE6-BF31-4153-B187-E5B97D89B42BQ36557899-81AB84FF-6AF6-4B04-A958-26609029F0FBQ36597282-8650826A-5017-482F-825F-1C2D317B1E41Q36764500-D5D08F40-0295-46DF-BF2E-8C5C0EC31879Q36957280-C97B501E-1CF8-4C7D-A2EF-7F49EDC9A78AQ36995320-7DF8E1BF-CE66-4882-BF27-01BCFE64181BQ37144048-C7C85AA0-260B-44E3-80E3-BD8EC04022FFQ37590908-E12D9263-6D80-436A-94B5-8FED7AB332E7Q37599583-84839C62-6439-4579-9D88-AC4C0BA69BC8Q37601317-0145A4BC-A1D6-432C-91A8-5AD9CA3B9A3AQ37690952-0B34DBD6-B031-4A76-BAAC-51DBA9D1BE65Q37824264-D5B98B7A-B290-4F4C-928A-3DA0DFA0F65AQ37859376-CC6F9A73-FE7F-44C3-A2E2-6BCDE31473F8Q37880364-B84319F8-091F-404D-B298-19DADC4D211A
P2860
Role of the innate immune system in the pathogenesis of multiple sclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@ast
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@en
type
label
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@ast
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@en
prefLabel
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@ast
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@en
P2860
P1476
Role of the innate immune system in the pathogenesis of multiple sclerosis.
@en
P2093
Alice Laroni
Roopali Gandhi
P2860
P356
10.1016/J.JNEUROIM.2009.10.015
P577
2010-04-01T00:00:00Z